Transforming the standard of care
Odyssey Therapeutics is a clinical-stage biopharmaceutical company developing next-generation small molecule and protein therapeutics for autoimmune and inflammatory diseases. Founded in 2021 and based in Boston, Odyssey uses a replicable and scalable drug discovery model combining AI-driven small molecule design with precision targeting of the innate immune system. The company has raised over $400 million across multiple financing rounds including a $213 million Series D in 2025.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountSep 2025
Dec 2023
Jan 2022
Jan 2021
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
Healthcare company applying technology to drug development by building nimble biotech subsidiarie...
Neuralink is building a brain-computer interface for medical needs and greater human potential.
